Creative Planning Clovis Oncology, Inc. Transaction History

Creative Planning

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.63 - $2.96 $67,816 - $318,629	-107,645 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.43 - $3.14 $153,932 - $338,005	107,645 New	107,645 $217,000
Q1 2020 May 05, 2020	SELL	$3.77 - $11.0 $830,595 - $2.42 Million	-220,317 Closed	0 $0
Q4 2019 Jan 30, 2020	BUY	$3.0 - $16.43 $334,875 - $1.83 Million	111,625 Added 102.7%	220,317 $2.3 Million
Q3 2019 Nov 01, 2019	SELL	$3.93 - $15.35 $120,485 - $470,600	-30,658 Reduced 22.0%	108,692 $427,000
Q2 2019 Jul 26, 2019	SELL	$12.81 - $25.67 $2,562 - $5,134	-200 Reduced 0.14%	139,350 $2.07 Million
Q1 2019 Apr 24, 2019	BUY	$17.66 - $30.28 $26,719 - $45,813	1,513 Added 1.1%	139,550 $3.46 Million
Q4 2018 Feb 01, 2019	BUY	$11.63 - $32.67 $579,871 - $1.63 Million	49,860 Added 56.55%	138,037 $2.48 Million
Q3 2018 Oct 25, 2018	BUY	$29.37 - $49.48 $264,330 - $445,320	9,000 Added 11.37%	88,177 $2.59 Million
Q2 2018 Jul 20, 2018	SELL	$42.06 - $62.4 $54,678 - $81,120	-1,300 Reduced 1.62%	79,177 $3.6 Million
Q1 2018 Apr 18, 2018	BUY	$50.12 - $67.72 $906,921 - $1.23 Million	18,095 Added 29.01%	80,477 $4.25 Million
Q4 2017 Jan 17, 2018	SELL	$57.69 - $84.58 $142,032 - $208,235	-2,462 Reduced 3.8%	62,382 $4.24 Million
Q3 2017 Oct 17, 2017	BUY	$67.17 - $84.81 $4.36 Million - $5.5 Million	64,844	64,844 $5.34 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.